Program: General Sessions
Tuesday, December 10, 2019: 7:30 AM-9:00 AM
Hall D, Level 2
(Orange County Convention Center)
Lecture Title:
Late Breaking Abstracts
Co-chairs:
Elisabeth Battinelli, MD, PhD, Brigham and Women's Hospital
and
Jason Gotlib, MD, MS, Stanford Cancer Center
Disclosures:
Gotlib: Seattle Genetics: Research Funding; Pharmacyclics: Research Funding; Promedior: Research Funding; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Incyte: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Gilead: Membership on an entity's Board of Directors or advisory committees, Research Funding; Deceiphera: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Blueprint Medicines: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Allakos: Honoraria, Membership on an entity's Board of Directors or advisory committees.
This highly anticipated session highlights the Program Committee's selections of the highest-impact abstracts, featuring substantive, novel, and groundbreaking data that were not available by the general abstract submission deadline and would otherwise not be presented at the ASH annual meeting.
See more of: General Sessions